Mallinckrodt Institute of Radiology, Washington University, St. Louis, MO (G.S.H., Y. L.).
Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany (J.D., J.T.T.).
Circ Cardiovasc Imaging. 2023 Jan;16(1):e014067. doi: 10.1161/CIRCIMAGING.122.014067. Epub 2023 Jan 17.
Inflammation is a key mechanistic contributor to the progression of cardiovascular disease, from atherosclerosis through ischemic injury and overt heart failure. Recent evidence has identified specific roles of immune cell subpopulations in cardiac pathogenesis that diverges between individual patients. Nuclear imaging approaches facilitate noninvasive and serial quantification of inflammation severity, offering the opportunity to predict eventual outcome, stratify patient risk, and guide novel targeted molecular therapies against specific leukocyte subpopulations. Here, we will discuss the established and emerging nuclear imaging methods to label and track exogenous and endogenous immune cells, with a particular focus on clinical situations in which targeted molecular inflammation imaging would be advantageous. The expanding options for imaging inflammation provide the foundation to bridge between molecular imaging and individual therapy.
炎症是心血管疾病进展的关键机制因素,从动脉粥样硬化到缺血损伤和心力衰竭。最近的证据表明,免疫细胞亚群在心脏发病机制中具有特定的作用,并且在个体患者之间存在差异。核医学成像方法可促进炎症严重程度的非侵入性和连续定量,提供预测最终结果、分层患者风险和指导针对特定白细胞亚群的新型靶向分子治疗的机会。在这里,我们将讨论已建立和新兴的核医学成像方法来标记和跟踪外源性和内源性免疫细胞,特别关注靶向分子炎症成像具有优势的临床情况。炎症成像选择的不断增加为分子成像和个体化治疗之间架起了桥梁。